title: Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?
abstract: The functional role of oxidative stress in cancer pathogenesis has long been a hotly debated topic. A study published this month in BMC Cancer by Goh et al., directly addresses this issue by using a molecular genetic approach, via an established mouse animal model of human breast cancer. More specifically, alleviation of mitochondrial oxidative stress, via transgenic over-expression of catalase (an anti-oxidant enzyme) targeted to mitochondria, was sufficient to lower tumor grade (from high-to-low) and to dramatically reduce metastatic tumor burden by >12-fold. Here, we discuss these new findings and place them in the context of several other recent studies showing that oxidative stress directly contributes to tumor progression and metastasis. These results have important clinical and translational significance, as most current chemo-therapeutic agents and radiation therapy increase oxidative stress, and, therefore, could help drive tumor recurrence and metastasis. Similarly, chemo- and radiation-therapy both increase the risk for developing a secondary malignancy, such as leukemia and/or lymphoma. To effectively reduce mitochondrial oxidative stress, medical oncologists should now re-consider the use of powerful anti-oxidants as a key component of patient therapy and cancer prevention. Please see related research article: http://www.biomedcentral.com/1471-2407/11/191.
authors: The Jefferson Stem Cell Biology and Regenerative Medicine Center, Philadelphia, PA, USA.
authors: Federica
authors: F
authors: Sotgia
authors: Ubaldo E
authors: UE
authors: Martinez-Outschoorn
authors: Michael P
authors: MP
authors: Lisanti
references: J Control Release. 2009 Jul 20;137(2):110-5
references: 19361547
references: BMC Cancer. 2011 May 23;11:191
references: 21605372
references: Am J Pathol. 2009 Jun;174(6):2035-43
references: 19411449
references: Biomed Pharmacother. 2005 May;59(4):209-14
references: 15862717
references: Cancer Biol Ther. 2008 Aug;7(8):1212-25
references: 18458534
references: Am J Pathol. 2009 Jun;174(6):2023-34
references: 19411448
references: Cell Cycle. 2009 Dec;8(23):3984-4001
references: 19923890
references: Cell Cycle. 2010 Jun 1;9(11):2201-19
references: 20519932
references: Am J Clin Nutr. 2009 May;89(5):1607S-1612S
references: 19321569
references: Cell Cycle. 2010 Sep 1;9(17):3534-51
references: 20864819
references: Am J Clin Nutr. 2003 Sep;78(3 Suppl):526S-532S
references: 12936945
references: Cell Cycle. 2010 Jun 15;9(12):2423-33
references: 20562526
references: Breast Cancer Res Treat. 2002 Nov;76(2):137-43
references: 12452451
references: Science. 2005 Jun 24;308(5730):1909-11
references: 15879174
references: Ann Med Interne (Paris). 1985;136(7):551-4
references: 3911832
references: Cancer Prev Res (Phila). 2010 Nov;3(11):1451-61
references: 20947488
references: Cell Cycle. 2010 Aug 15;9(16):3256-76
references: 20814239
references: Adv Drug Deliv Rev. 2009 Apr 28;61(4):319-26
references: 19385054
references: Cancer Cell. 2010 Feb 17;17(2):135-47
references: 20138012
references: Cancer Biol Ther. 2010 Jul 15;10(2):135-43
references: 20431349
references: Mol Cell Biol. 2005 Sep;25(17):7758-69
references: 16107721
references: Am J Pathol. 2009 Mar;174(3):746-61
references: 19234134
references: Cell Cycle. 2010 Sep 1;9(17):3485-505
references: 20861672
references: Int J Cancer. 1992 May 28;51(3):476-80
references: 1592538
references: Am J Pathol. 2006 Nov;169(5):1784-801
references: 17071600
references: EMBO Mol Med. 2010 Jun;2(6):211-30
references: 20535745
references: Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):262-71
references: 21177425
references: Clin Cancer Res. 2009 Dec 1;15(23):7434-40
references: 19920101
references: Aging (Albany NY). 2010 Apr;2(4):185-99
references: 20442453
references: Cell Cycle. 2009 Aug;8(15):2420-4
references: 19556867
references: Cell Cycle. 2010 Sep 1;9(17):3515-33
references: 20855962
references: Cell Cycle. 2010 Nov 1;9(21):4297-306
references: 21051947
references: Cancer Biol Ther. 2011 Feb 15;11(4):383-94
references: 21150282
references: Cancer Biol Ther. 2010 Sep 15;10(6):537-42
references: 20861671
references: J Biol Chem. 2004 Dec 3;279(49):51630-46
references: 15355971
references: Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):101-11
references: 21119073
references: Cancer Res. 2004 Oct 1;64(19):7022-9
references: 15466195
references: Cancer Res. 2000 Oct 15;60(20):5625-9
references: 11059751
references: Neuroepidemiology. 1993;12(1):28-36
references: 8327020